vs
Apellis Pharmaceuticals, Inc.（APLS）与MCGRATH RENTCORP（MGRC）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是MCGRATH RENTCORP的1.0倍（$199.9M vs $198.5M），MCGRATH RENTCORP净利率更高（13.6% vs -29.5%，领先43.1%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -12.6%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -3.4%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
麦格拉思租赁公司是主营北美市场的B2B租赁服务商，核心业务包括可搬迁模块化办公与教学建筑、便携式存储单元及电子测试测量设备租赁，服务覆盖建筑、教育、工业、科技等多个行业领域。
APLS vs MGRC — 直观对比
营收规模更大
APLS
是对方的1.0倍
$198.5M
营收增速更快
APLS
高出6.6%
-12.6%
净利率更高
MGRC
高出43.1%
-29.5%
两年增速更快
APLS
近两年复合增速
-3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $198.5M |
| 净利润 | $-59.0M | $27.0M |
| 毛利率 | — | 48.8% |
| 营业利润率 | -25.6% | 21.9% |
| 净利率 | -29.5% | 13.6% |
| 营收同比 | -5.9% | -12.6% |
| 净利润同比 | -62.2% | -4.2% |
| 每股收益（稀释后） | $-0.40 | $1.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMGRC
| Q1 26 | — | $198.5M | ||
| Q4 25 | $199.9M | $256.8M | ||
| Q3 25 | $458.6M | $256.4M | ||
| Q2 25 | $178.5M | $235.6M | ||
| Q1 25 | $166.8M | $195.4M | ||
| Q4 24 | $212.5M | $243.7M | ||
| Q3 24 | $196.8M | $266.8M | ||
| Q2 24 | $199.7M | $212.6M |
净利润APLSMGRC
| Q1 26 | — | $27.0M | ||
| Q4 25 | $-59.0M | $49.8M | ||
| Q3 25 | $215.7M | $42.3M | ||
| Q2 25 | $-42.2M | $36.0M | ||
| Q1 25 | $-92.2M | $28.2M | ||
| Q4 24 | $-36.4M | $38.9M | ||
| Q3 24 | $-57.4M | $149.3M | ||
| Q2 24 | $-37.7M | $20.6M |
毛利率APLSMGRC
| Q1 26 | — | 48.8% | ||
| Q4 25 | — | 50.1% | ||
| Q3 25 | — | 46.5% | ||
| Q2 25 | — | 47.0% | ||
| Q1 25 | — | 49.3% | ||
| Q4 24 | — | 47.1% | ||
| Q3 24 | — | 46.5% | ||
| Q2 24 | — | 48.6% |
营业利润率APLSMGRC
| Q1 26 | — | 21.9% | ||
| Q4 25 | -25.6% | 28.9% | ||
| Q3 25 | 48.7% | 26.0% | ||
| Q2 25 | -18.6% | 24.3% | ||
| Q1 25 | -50.0% | 23.3% | ||
| Q4 24 | -12.3% | 25.9% | ||
| Q3 24 | -24.0% | 28.0% | ||
| Q2 24 | -14.7% | 25.6% |
净利率APLSMGRC
| Q1 26 | — | 13.6% | ||
| Q4 25 | -29.5% | 19.4% | ||
| Q3 25 | 47.0% | 16.5% | ||
| Q2 25 | -23.6% | 15.3% | ||
| Q1 25 | -55.3% | 14.4% | ||
| Q4 24 | -17.1% | 16.0% | ||
| Q3 24 | -29.2% | 56.0% | ||
| Q2 24 | -18.9% | 9.7% |
每股收益（稀释后）APLSMGRC
| Q1 26 | — | $1.10 | ||
| Q4 25 | $-0.40 | $2.02 | ||
| Q3 25 | $1.67 | $1.72 | ||
| Q2 25 | $-0.33 | $1.46 | ||
| Q1 25 | $-0.74 | $1.15 | ||
| Q4 24 | $-0.30 | $1.58 | ||
| Q3 24 | $-0.46 | $6.08 | ||
| Q2 24 | $-0.30 | $0.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | — |
| 总资产 | $1.1B | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSMGRC
| Q1 26 | — | — | ||
| Q4 25 | $466.2M | $295.0K | ||
| Q3 25 | $479.2M | $7.3M | ||
| Q2 25 | $370.0M | $1.5M | ||
| Q1 25 | $358.4M | $3.4M | ||
| Q4 24 | $411.3M | $807.0K | ||
| Q3 24 | $396.9M | $4.1M | ||
| Q2 24 | $360.1M | $9.4M |
股东权益APLSMGRC
| Q1 26 | — | — | ||
| Q4 25 | $370.1M | $1.2B | ||
| Q3 25 | $401.2M | $1.2B | ||
| Q2 25 | $156.3M | $1.2B | ||
| Q1 25 | $164.2M | $1.1B | ||
| Q4 24 | $228.5M | $1.1B | ||
| Q3 24 | $237.1M | $1.1B | ||
| Q2 24 | $264.3M | $954.2M |
总资产APLSMGRC
| Q1 26 | — | $2.4B | ||
| Q4 25 | $1.1B | $2.4B | ||
| Q3 25 | $1.1B | $2.4B | ||
| Q2 25 | $821.4M | $2.3B | ||
| Q1 25 | $807.3M | $2.2B | ||
| Q4 24 | $885.1M | $2.3B | ||
| Q3 24 | $901.9M | $2.3B | ||
| Q2 24 | $904.5M | $2.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $42.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 1.57× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSMGRC
| Q1 26 | — | $42.4M | ||
| Q4 25 | $-14.2M | $80.9M | ||
| Q3 25 | $108.5M | $65.1M | ||
| Q2 25 | $4.4M | $55.8M | ||
| Q1 25 | $-53.4M | $53.9M | ||
| Q4 24 | $19.4M | $36.8M | ||
| Q3 24 | $34.1M | $199.0M | ||
| Q2 24 | $-8.3M | $79.2M |
自由现金流APLSMGRC
| Q1 26 | — | — | ||
| Q4 25 | $-14.3M | $69.8M | ||
| Q3 25 | $108.3M | $53.5M | ||
| Q2 25 | $4.4M | $38.2M | ||
| Q1 25 | $-53.4M | $49.9M | ||
| Q4 24 | $19.3M | $32.6M | ||
| Q3 24 | — | $193.0M | ||
| Q2 24 | $-8.4M | $74.4M |
自由现金流率APLSMGRC
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 27.2% | ||
| Q3 25 | 23.6% | 20.8% | ||
| Q2 25 | 2.5% | 16.2% | ||
| Q1 25 | -32.0% | 25.5% | ||
| Q4 24 | 9.1% | 13.4% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | -4.2% | 35.0% |
资本支出强度APLSMGRC
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 4.3% | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 0.0% | 7.5% | ||
| Q1 25 | 0.0% | 2.0% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.0% | 2.3% |
现金转化率APLSMGRC
| Q1 26 | — | 1.57× | ||
| Q4 25 | — | 1.62× | ||
| Q3 25 | 0.50× | 1.54× | ||
| Q2 25 | — | 1.55× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 3.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MGRC
| Rental | $126.7M | 64% |
| Rental related services | $35.6M | 18% |
| Sales | $34.0M | 17% |
